Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Anti-Ulcer Activity of Tuber Extracts of Solanum tuberosum (Solanaceae) in Rats

Anti-Ulcer Activity of Tuber Extracts of Solanum tuberosum (Solanaceae) in Rats Acta Fac. Pharm. Univ. Comen. LXII, 2015 (Suppl XI): 1. ISSN 1338-6786 (online) and ISSN 0301-2298 (print version), DOI: 10.1515/afpuc-2015-0029 ACTA FACULTATIS PHARMACEUTICAE UNIVERSITATIS COMENIANAE MUDr. Eva Vivodová1 , PharmDr. Tatiana Foltánová PhD.2 Ministry of Health, Section of Health, Bratislava, Slovak Republic 2 Comenius University, Faculty of Pharmacy, Bratislava, Slovak Republic Ministerstvo zdravotníctva, Sekcia zdravia, Bratislava, Slovenská republika Univerzita Komenského v Bratislave, Farmaceutická fakulta, Bratislava, Slovenská republika DEAR COLLEAGUES, DEAR READERS Progress in the life sciences and related technologies offers the potential opportunity to bring a wide range of diagnostic methods and therapies to patients with rare diseases. Despite the improvement made over thelpast years in the field of rare diseases, information on rare diseases is still limited. A comprehensive and evidence-based approach is missing and thus mainly at the member states level. In Slovakia, the situation is not different. Similarly to other small countries, Slovakia is facing its own problems as small number of severely disabled or life-threatening patients, who are, on one hand, hard to be recognized by the healthcare system and, on the other hand, very expensive for the health and social system. Another issue is low number of specialist for rare diseases, closely allied with complexity and comprehensiveness of rare disease, a circulus vitiosus starting and ending by rare disease patients and their support for equal and sustainable health and social care, comparable with other groups of patients with more prevalent diseases and defined in the rare disease legislation. By the creation of the best practices for rare diseases, different European or even international recommendations are of big advantage, experience matters. On the other hand, these have to be adjusted to the national health policy. Independently of all this obstacles or advantages, the base is to support the evolution and growth of professionals. It is a pleasure for us to introduce fourth special issue of this university journal, focused on rare diseases. We believe that this is the best opportunity of how to encourage researchers to publish scientific information and new findings to promote the exchange of scientific knowledge and to support specialisation of professionals in rare diseases. Which fields of rare diseases are the point of interest in the Slovak republic? In this issue, we present a big step forward in complex genetic analysis of hereditary breast ovarian cancer, which is further elaborating the health care in the field of medical genetics in this precise condition. Slovakia is the second country with most described cases of alkaptonuria. The genetics of the Slovak patients is thus bringing a lot of new knowledge into this topic. Diagnostics of phenylketonuria in the Slovak republic is one of the models thah might inspire other countries or other rare diseases. About the whole model you can read in next pages. Thanks to long-lasting support of the rheumatic diseases at the National Institute of Rheumatic Diseases in Piestany, we are ready to provide professionals to rare disease with rheumatic patterns as Sjongrens syndrome or rheumatic conditions ir patients with Klinefelter syndrome. We believe in inspiration and support others and thus, at the national as well as international level, the creation of new cooperation between the scientific groups. Enjoy the reading * E-mail: eva.vivodova@health.gov.sk © Acta Facultatis Pharmaceuticae Universitatis Comenianae http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Acta Facultatis Pharmaceuticae Universitatis Comenianae de Gruyter

Anti-Ulcer Activity of Tuber Extracts of Solanum tuberosum (Solanaceae) in Rats

Loading next page...
 
/lp/de-gruyter/anti-ulcer-activity-of-tuber-extracts-of-solanum-tuberosum-solanaceae-xK5mFM0epb
Publisher
de Gruyter
Copyright
Copyright © 2015 by the
ISSN
1338-6786
eISSN
1338-6786
DOI
10.1515/afpuc-2015-0029
Publisher site
See Article on Publisher Site

Abstract

Acta Fac. Pharm. Univ. Comen. LXII, 2015 (Suppl XI): 1. ISSN 1338-6786 (online) and ISSN 0301-2298 (print version), DOI: 10.1515/afpuc-2015-0029 ACTA FACULTATIS PHARMACEUTICAE UNIVERSITATIS COMENIANAE MUDr. Eva Vivodová1 , PharmDr. Tatiana Foltánová PhD.2 Ministry of Health, Section of Health, Bratislava, Slovak Republic 2 Comenius University, Faculty of Pharmacy, Bratislava, Slovak Republic Ministerstvo zdravotníctva, Sekcia zdravia, Bratislava, Slovenská republika Univerzita Komenského v Bratislave, Farmaceutická fakulta, Bratislava, Slovenská republika DEAR COLLEAGUES, DEAR READERS Progress in the life sciences and related technologies offers the potential opportunity to bring a wide range of diagnostic methods and therapies to patients with rare diseases. Despite the improvement made over thelpast years in the field of rare diseases, information on rare diseases is still limited. A comprehensive and evidence-based approach is missing and thus mainly at the member states level. In Slovakia, the situation is not different. Similarly to other small countries, Slovakia is facing its own problems as small number of severely disabled or life-threatening patients, who are, on one hand, hard to be recognized by the healthcare system and, on the other hand, very expensive for the health and social system. Another issue is low number of specialist for rare diseases, closely allied with complexity and comprehensiveness of rare disease, a circulus vitiosus starting and ending by rare disease patients and their support for equal and sustainable health and social care, comparable with other groups of patients with more prevalent diseases and defined in the rare disease legislation. By the creation of the best practices for rare diseases, different European or even international recommendations are of big advantage, experience matters. On the other hand, these have to be adjusted to the national health policy. Independently of all this obstacles or advantages, the base is to support the evolution and growth of professionals. It is a pleasure for us to introduce fourth special issue of this university journal, focused on rare diseases. We believe that this is the best opportunity of how to encourage researchers to publish scientific information and new findings to promote the exchange of scientific knowledge and to support specialisation of professionals in rare diseases. Which fields of rare diseases are the point of interest in the Slovak republic? In this issue, we present a big step forward in complex genetic analysis of hereditary breast ovarian cancer, which is further elaborating the health care in the field of medical genetics in this precise condition. Slovakia is the second country with most described cases of alkaptonuria. The genetics of the Slovak patients is thus bringing a lot of new knowledge into this topic. Diagnostics of phenylketonuria in the Slovak republic is one of the models thah might inspire other countries or other rare diseases. About the whole model you can read in next pages. Thanks to long-lasting support of the rheumatic diseases at the National Institute of Rheumatic Diseases in Piestany, we are ready to provide professionals to rare disease with rheumatic patterns as Sjongrens syndrome or rheumatic conditions ir patients with Klinefelter syndrome. We believe in inspiration and support others and thus, at the national as well as international level, the creation of new cooperation between the scientific groups. Enjoy the reading * E-mail: eva.vivodova@health.gov.sk © Acta Facultatis Pharmaceuticae Universitatis Comenianae

Journal

Acta Facultatis Pharmaceuticae Universitatis Comenianaede Gruyter

Published: Dec 1, 2015

References